MAPT and neurodegenerative disease: Among neurodegenerative diseases, Alzheimer’s dementia (AD), characterized by brain amyloid plaques and neurofibrillary tangles of phosphorylated tau (P-tau) protein deposits, is the most common, affecting 24 million people worldwide.